Pfizer Inc (PFE)

Debt-to-assets ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Long-term debt US$ in thousands 61,538,000 32,884,000 36,195,000 37,133,000 35,955,000
Total assets US$ in thousands 227,000,000 197,000,000 181,000,000 154,229,000 167,594,000
Debt-to-assets ratio 0.27 0.17 0.20 0.24 0.21

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $61,538,000K ÷ $227,000,000K
= 0.27

The debt-to-assets ratio for Pfizer Inc. has fluctuated over the past five years, ranging from 0.18 to 0.32. In 2023, the ratio increased to 0.32 from 0.18 in the previous year, indicating that a higher proportion of Pfizer's assets are financed through debt. This suggests that Pfizer may have taken on more debt relative to its assets in the most recent year. Despite the increase, the debt-to-assets ratio remains below 1, indicating that Pfizer's assets still predominantly finance its operations rather than debt. It is important for investors and stakeholders to monitor this ratio to assess Pfizer's leverage and financial risk over time.


Peer comparison

Dec 31, 2023


See also:

Pfizer Inc Debt to Assets